Imugene Ltd (ASX:IMU)

Imugene Ltd (ASX:IMU)

Share Price
$ 0.02
-0.001 (-5.56 %)
Market Cap
$61.37 m
Proactive Investors - Run By Investors For Investors

Imugene Ltd

Imugene Ltd (ASX:IMU) is listed on the Australian Securities Exchange.

Market: ASX:IMU
52-week High/Low: A$0.036 / A$0.015
Sector: Pharma & Biotech
Market Cap: $61.37 m
col 3
col 4
col 5
col 6

Big Picture – A Deep Dive Examination of Imugene Ltd

Imugene Ltd Timeline

Imugene Ltd (ASX:IMU) has promoted Leslie Chong to the position of chief executive officer, as the company prepares for the critical milestone of dosing the patients in the gastric cancer Phase 1b/2 clinical trial in Asia.

© Proactive Investors 2019

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use